January 3, 2025 02:28 PM EST

Florida car dealer joins insulin pricing fight against Eli Lilly, Sanofi

Nicole DeFeudis

Editor

A Florida-based car dealer has joined mounting litigation against Eli Lilly, Novo Nordisk and Sanofi over what it calls the “exorbitant” price of insulin. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Florida car dealer joins insulin pricing fight against Eli Lilly, Sanofi

Nicole DeFeudis

Editor

Sign up to read this article for free.

After CagriSema, eyes are on Lilly’s oral GLP-1 as next key obesity play

A look at biotech's year of the megaround

Regeneron buys London-based ocular biotech

CagriSema’s weight loss data disappointed. What does Novo do next?

Neumora's major depression drug flunks first of three Phase 3 trials

Roche circles back to China biotech with $80M deal for lung cancer ADC

Flori­da car deal­er joins in­sulin pric­ing fight against Eli Lil­ly, Sanofi

Nicole DeFeudis

Editor

Sign up to read this article for free.

more like this

Af­ter Ca­griSe­ma, eyes are on Lil­ly’s oral GLP-1 as next key obe­si­ty play

A look at biotech's year of the megaround

Re­gen­eron buys Lon­don-based oc­u­lar biotech

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Neu­mora's ma­jor de­pres­sion drug flunks first of three Phase 3 tri­als

Roche cir­cles back to Chi­na biotech with $80M deal for lung can­cer ADC

Florida car dealer joins insulin pricing fight against Eli Lilly, Sanofi

After CagriSema, eyes are on Lilly’s oral GLP-1 as next key obesity play

Regeneron buys London-based ocular biotech

CagriSema’s weight loss data disappointed. What does Novo do next?

Neumora's major depression drug flunks first of three Phase 3 trials

Roche circles back to China biotech with $80M deal for lung cancer ADC